PFIZER

Sep 09 2025HEALTH

Awarding Trump for COVID-19 Vaccine Push: A Debate

The CEO of Pfizer, Albert Boura, has suggested that former President Donald Trump should be considered for the Nobel Peace Prize. This is due to Trump's role in speeding up the creation and distribution of the COVID-19 vaccine. Boura highlighted the success of Operation Warp Speed, a program started by Trump in 2020. This program helped prevent economic disaster and ...

reading time about 1 minute
Jul 30 2025HEALTH

Pregnant Women's Health at Risk Due to Penicillin Shortage

A critical shortage of a key antibiotic is raising concerns about the health of pregnant women. Pfizer, a major pharmaceutical company, has announced that it will have limited supplies of Bicillin LA. This drug is crucial for treating syphilis in pregnant women. The shortage comes after Pfizer recalled certain batches of Bicillin L-A due to contamination issues. Syp...

reading time about 1 minute
Jun 02 2025HEALTH

Pfizer's CEO Speaks Out on Vaccine Controversy

The US Department of Health and Human Services recently made a bold move. They ended a contract with Moderna. The contract was for developing an mRNA vaccine for bird flu. The reason given was that mRNA technology is not well-tested. This decision sparked a response from Pfizer's CEO, Dr. Albert Bourla. He strongly disagreed with the claim that mRNA vaccines are unde...

reading time about 1 minute
May 19 2025POLITICS

Text Messages Under Scrutiny: EU Court Orders Release of Pfizer Communications

A significant ruling came down from the European Court of Justice. The court ordered the release of text messages exchanged between European Commission President Ursula von der Leyen and Pfizer CEO Albert Bourla. This decision came after a lengthy battle for transparency. The New York Times had requested access to these messages. They wanted to see all commu...

reading time about 1 minute
Feb 04 2025BUSINESS

Pfizer's Q4 2024: Beating Expectations, Facing Challenges

Pfizer recently shared its fourth-quarter 2024 earnings. Their reported sales for COVID-19 products skyrocketed beyond what experts had guessed. This achievement was made possible by the company’s ongoing efforts to reduce costs. Shares of Pfizer went up by 2% in early trading. This jump came after they reported earnings, with results that were much better t...

reading time about 1 minute
Jan 07 2025HEALTH

Sounds in Health: Spotting Respiratory Issues with AI

Imagine you're a doctor. You need to know if a patient's cough or sneeze is just a passing thing or a sign of something bigger. That's where machine learning comes in. Researchers created an automatic system to spot sneezes and coughs, sounds that can hint at respiratory problems. The goal? Early diagnosis and quick treatment. This project took on a challenge called...

reading time about 1 minute
Nov 22 2024EDUCATION

Chat with Stephen E. Fienberg: Unveiling the World of Statistics

Stephen E. Fienberg, a distinguished statistician, was recently interviewed as part of a special series honoring the late Professor Harry O. Posten. The chat, supported by Pfizer Global Research-Connecticut, the American Statistical Association, and the University of Connecticut-Storrs, dived into Fienberg's insights and the future of statistics. Fienberg shared his...

reading time about 1 minute
Nov 22 2024HEALTH

Boosting Vaccine Efficacy with Bayesian Methods

Did you know that the way we estimate how well vaccines work can be improved? Currently, scientists use a method that relies on the total number of cases to figure out vaccine efficacy. But a new approach, called the full Bayesian method, is making waves. This method is like a smarter way to estimate how effective a vaccine is. Let's take a look at the BioNTech/Pfize...

reading time about 1 minute
Oct 30 2024BUSINESS

Pfizer's Surprising Q3 Win: Paxlovid and Vaccines Boost Sales

Pfizer recently shared impressive Q3 results that overshot expectations, thanks to its Covid vaccine and antiviral pill, Paxlovid. The drug giant raised its earnings and revenue projections for the year. Despite the positive news, shares dropped by over 2%. Pfizer's CEO, Albert Bourla, is under pressure from activist investor Starboard Value, which believes the compa...

reading time less than a minute
Oct 30 2024BUSINESS

Pfizer's COVID-19 Meds Boost Sales: What's Next?

Pfizer's third-quarter earnings just came in, and guess what? They're way better than expected! The company's making a lot more money, thanks to a big demand for their COVID-19 treatments. Their best-selling drug, Paxlovid, brought in a whopping $2. 7 billion in the third quarter alone. This is a major win for Pfizer's CEO, Albert Bourla, who's been dealing with some...

reading time less than a minute